Precise Bio
Lior Rosenberg Belmaker has worked in the field of biology research for over a decade. In 2019, they began working as a Biology Research Manager for Precise Bio. Prior to that, they were a Research Manager at Cell Cure Neuroscience from 2012-2019, where they developed assays for testing product potency and focused on developing new pipeline products. From 2010-2012, they were a Post Doc at Yale University, where they studied the biological mechanisms underlying Autism. From 2008-2010, they were a Research Scientist, PhD at Histogen, where they worked to detect the presence of Wnt proteins and their activity in media produced by newborn human fibroblasts. Lastly, from 2007-2008, they were a Postdoctoral Fellowship in Immunology at Universitat Ben Gurion Ba-Negev, where they studied the mechanisms by which receptors, expressed by natural killer cells, trigger natural killer lysis of tumor and virus-infected cells.
Lior Rosenberg Belmaker received their PhD in Cell and Animal Physiology from Ben-Gurion University of the Negev in 2006. Lior had previously received their BSc in the same field from the same university in 2001.
This person is not in any offices
Precise Bio
Precise Bio is a regenerative medicine company that develops and commercializes 4D bio-fabricated functional tissues and organs.